There is a positive correlation between the elevated expression of USP21 and high mortality in patients; therefore, small interfering RNA (siRNA) knockdown of USP21 and consequent reduction of tumor cell proliferation may be a promising treatment for DLBCL (Ma et al., 2021). Here, USP21 is linked to neoplasm.